PRESS RELEASE published on 09/30/2024 at 23:00, 2 years 1 month ago Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
PRESS RELEASE published on 09/30/2024 at 23:00, 2 years 1 month ago Biophytis publie ses comptes semestriels et fait le point sur ses activités Biophytis publie ses comptes semestriels et fait le point sur ses activités. La société présente ses résultats financiers pour le premier semestre 2024 et annonce les prochaines étapes de développement de ses programmes cliniques Biophytis Partenariat BIO101 Obésité Comptes Semestriels
REGULATED PRESS RELEASE published on 09/30/2024 at 23:00, 2 years 1 month ago Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America Financial Results Biophytis Latin America BIO101 OBA Program
REGULATED PRESS RELEASE published on 09/30/2024 at 23:00, 2 years 1 month ago Biophytis publie ses comptes semestriels et fait le point sur ses activités Biophytis publie ses résultats semestriels 2024, annonce son programme OBA dans l'obésité et un accord avec Blanver pour l'Amérique Latine Résultats Semestriels Biophytis Biotechnologie Programme OBA Accord Blanver
BRIEF published on 07/22/2024 at 08:17, 2 years 3 months ago Biophytis Enters Asia Market with Strategic Partnerships Biophytis Pharmaceutical Partnerships Market Expansion Asia
BRIEF published on 07/22/2024 at 08:17, 2 years 3 months ago Biophytis entre sur le marché asiatique avec des partenariats stratégiques Biophytis Partenariats Asie L'expansion Du Marché Pharmaceutique
PRESS RELEASE published on 07/22/2024 at 08:12, 2 years 3 months ago Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia Biophytis signs partnership contracts with local agents in Asia to accelerate deployment of BIO101 drug candidate, targeting age-related diseases in key markets like Japan and China Biophytis Partnership Asia Age-related Diseases BIO101
PRESS RELEASE published on 07/22/2024 at 08:12, 2 years 3 months ago Biophytis déploie sa stratégie de partenariats et signe deux contrats avec des agents locaux en Asie Biophytis déploie sa stratégie de partenariats en Asie en signant deux contrats avec des agents locaux. Objectif : accélérer le déploiement du candidat-médicament BIO101 dans la région Biophytis Partenariats Asie BIO101 Agents Locaux
BRIEF published on 07/22/2024 at 07:05, 2 years 3 months ago Biophytis déploie sa stratégie de partenariats en Asie Développement Partenariats Asie Santé Biophonobiophytis
BRIEF published on 07/22/2024 at 07:05, 2 years 3 months ago Biophytis Signs Contracts with Local Agents in Asia Biotechnology Pharmaceutical Partnerships Age-related Diseases Asia Market
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 11 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 21 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 27 minutes ago Custodian Property Income REIT plc: Further momentum with majority share-based acquisition strategy, purchasing an £11.0m property portfolio from eight syndicated investment vehicles
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 27 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026